MicroRNA-204 plays a role as a tumor suppressor in Newcastle disease virus-induced oncolysis in lung cancer A549 cells

Advances in the Study of Antitumour Immunotherapy for Newcastle Disease Virus

The oncolytic Newcastle disease virus as an effective immunotherapeutic strategy against glioblastoma

Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged

Oncolytic effects of the recombinant Newcastle disease virus, rAF-IL12, against colon cancer cells in vitro and in tumor-challenged NCr-Foxn1nu nude mice

Newcastle Disease Virus at the Forefront of Cancer Immunotherapy

Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials

Emerging Immunotherapies in the Treatment of Brain Metastases

Evaluation of Apoptosis Induction by Newcastle Disease Virus LaSota Strain in Human Breast Carcinoma Cells

NDV-D90 inhibits 17β-estradiol-mediated resistance to apoptosis by differentially modulating classic and nonclassic estrogen receptors in breast cancer cells